Eli Lilly Stock Price Surge and Target Upgrade by Citi

Eli Lilly stock surged over 2% to $1011 per share, following Citi's target price increase to $1,500 from $1,250. This adjustment suggests a potential upside of more than 50% from current levels, reinforcing a positive outlook on the company's performance. Additionally, Citigroup has maintained its 'Buy' rating for Eli Lilly, further indicating confidence in the company's potential growth.
Related stocks
 
Related News
no data

No related news

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10